JP2024544936A5 - - Google Patents

Info

Publication number
JP2024544936A5
JP2024544936A5 JP2024527607A JP2024527607A JP2024544936A5 JP 2024544936 A5 JP2024544936 A5 JP 2024544936A5 JP 2024527607 A JP2024527607 A JP 2024527607A JP 2024527607 A JP2024527607 A JP 2024527607A JP 2024544936 A5 JP2024544936 A5 JP 2024544936A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
chain variable
light chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024527607A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024544936A (ja
Filing date
Publication date
Priority claimed from GBGB2116386.0A external-priority patent/GB202116386D0/en
Priority claimed from GBGB2116387.8A external-priority patent/GB202116387D0/en
Priority claimed from GBGB2116388.6A external-priority patent/GB202116388D0/en
Application filed filed Critical
Priority claimed from PCT/EP2022/081676 external-priority patent/WO2023084055A1/en
Publication of JP2024544936A publication Critical patent/JP2024544936A/ja
Publication of JP2024544936A5 publication Critical patent/JP2024544936A5/ja
Pending legal-status Critical Current

Links

JP2024527607A 2021-11-12 2022-11-11 組成物 Pending JP2024544936A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB2116388.6 2021-11-12
GBGB2116386.0A GB202116386D0 (en) 2021-11-12 2021-11-12 Compositions
GB2116386.0 2021-11-12
GBGB2116387.8A GB202116387D0 (en) 2021-11-12 2021-11-12 Compositions
GB2116387.8 2021-11-12
GBGB2116388.6A GB202116388D0 (en) 2021-11-12 2021-11-12 Compositions
PCT/EP2022/081676 WO2023084055A1 (en) 2021-11-12 2022-11-11 Compositions

Publications (2)

Publication Number Publication Date
JP2024544936A JP2024544936A (ja) 2024-12-05
JP2024544936A5 true JP2024544936A5 (enExample) 2025-11-19

Family

ID=84389199

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024527607A Pending JP2024544936A (ja) 2021-11-12 2022-11-11 組成物

Country Status (4)

Country Link
US (1) US20250011398A1 (enExample)
EP (1) EP4430070A1 (enExample)
JP (1) JP2024544936A (enExample)
WO (1) WO2023084055A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021195418A1 (en) 2020-03-26 2021-09-30 Vanderbilt University Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
TW202342510A (zh) 2022-02-18 2023-11-01 英商Ｒｑ生物科技有限公司 抗體
CR20240528A (es) 2022-04-29 2025-04-04 Astrazeneca Uk Ltd Anticuerpos contra el sars-cov-2 y métodos para utilizarlos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023517234A (ja) * 2020-03-09 2023-04-24 アブセレラ バイオロジクス インコーポレイテッド 抗コロナウイルス抗体および使用の方法
CR20220552A (es) * 2020-04-02 2023-01-17 Regeneron Pharma Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno
US20240043507A1 (en) * 2021-02-04 2024-02-08 Rq Biotechnology Limited Antibodies

Similar Documents

Publication Publication Date Title
CN107847595B (zh) 特异性针对过度磷酸化τ蛋白的抗体及其使用方法
JP2026053563A (ja) 補体関連疾患のための融合タンパク質構築物
RU2770209C2 (ru) Терапевтические антитела против лиганда cd40
CN113508132B (zh) 人源化抗Aβ单克隆抗体及其应用
CN106795219A (zh) 抗il‑17抗体及其生产和使用的方法
JP2010502208A (ja) 半減期の長い血清アルブミン結合タンパク質
WO2006122787A1 (en) Serum albumin binding proteins
JP2019521647A5 (enExample)
WO2022184074A1 (zh) 含抗tslp抗体的药物组合物
JP2013543384A5 (enExample)
AU2015359262B2 (en) Method for the treatment of idiopathic pulmonary fibrosis
CN114736291B (zh) 特异性结合发热伴血小板减少综合征病毒的囊膜蛋白Gn的人源单克隆抗体及其用途
CN101969999A (zh) 抗nogo-66受体(ngr)的中和单克隆抗体及其用途
WO2024120479A1 (zh) 一种针对IgE的抗体或其抗原结合片段以及Fc变体
JP2024177499A (ja) 血液脳関門輸送の促進のためのヒト化され安定化されたｆｃ５バリアント
US20250059266A1 (en) Antibodies for treating alpha-synucleinopathies
JP2026071342A (ja) 抗ＩｇＥ改変抗体及びその適用
CN103906532B (zh) 结合磷酰胆碱（pc）和/或pc结合物的抗体
CN120981244A (zh) Vhh抗体和其用途
CN113508133B (zh) 人源化抗Aβ单克隆抗体及其应用
JP2025517120A5 (enExample)
WO2023143445A1 (zh) 用于治疗hbv感染及相关疾病的表位肽及抗体
KR20260005361A (ko) 항 s100a8/a9 항체 및 그 용도
CA3143957A1 (en) Anti-pd-l1 antibodies
JP7010491B2 (ja) ヒト化抗ｒａｇｅ抗体